The JAZZ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the JAZZ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The JAZZ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View JAZZ Detailed Price Forecast - CNN Money||View JAZZ Detailed Summary - Google Finance|
|View JAZZ Detailed Summary - Yahoo! Finance||View JAZZ Stock Research & Analysis - Zacks.com|
|View JAZZ Trends & Analysis - Trade-Ideas||View JAZZ Major Holders - Barrons|
|View JAZZ Call Transcripts - NASDAQ||View JAZZ Breaking News & Analysis - Seeking Alpha|
|View JAZZ Annual Report - CompanySpotlight.com||View JAZZ OTC Short Report - OTCShortReport.com|
|View JAZZ Fundamentals - TradeKing||View JAZZ SEC Filings - Bar Chart|
|View Historical Prices for JAZZ - The WSJ||View Performance/Total Return for JAZZ - Morningstar|
|View the Analyst Estimates for JAZZ - MarketWatch||View the Earnings History for JAZZ - CNBC|
|View the JAZZ Earnings - StockMarketWatch||View JAZZ Buy or Sell Recommendations - MacroAxis|
|View the JAZZ Bullish Patterns - American Bulls||View JAZZ Short Pain Metrics - ShortPainBot.com|
|View JAZZ Stock Mentions - StockTwits||View JAZZ Stock Mentions - PennyStockTweets|
|View JAZZ Stock Mentions - Twitter||View JAZZ Investment Forum News - Investor Hub|
|View JAZZ Stock Mentions - Yahoo! Message Board||View JAZZ Stock Mentions - Seeking Alpha|
|View Insider Transactions for JAZZ - SECform4.com||View Insider Transactions for JAZZ - Insider Cow|
|View JAZZ Major Holdings Summary - CNBC||View Insider Disclosure for JAZZ - OTC Markets|
|View Insider Transactions for JAZZ - Yahoo! Finance||View Institutional Holdings for JAZZ - NASDAQ|
|View JAZZ Stock Insight & Charts - FinViz.com||View JAZZ Investment Charts - StockCharts.com|
|View JAZZ Stock Overview & Charts - BarChart||View JAZZ User Generated Charts - Trading View|
Jazz Pharmaceuticals to Report 2018 First Quarter Financial Results on May 8, 2018
Posted on Tuesday April 24, 2018
DUBLIN , April 24, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2018 first quarter financial results on Tuesday, May 8, 2018 , after the close of ...
Jazz Pharmaceuticals’ 2018 Guidance and Analyst Recommendations
Posted on Thursday April 19, 2018
Jazz Pharmaceuticals (JAZZ) estimates that in fiscal 2018, its net revenue will be $1.86 billion–$1.93 billion. Its estimated GAAP (generally accepted accounting principles) gross margin is 93% for 2018.
Vyxeos Could Be Jazz Pharmaceuticals’ Long-Term Growth Driver
Posted on Thursday April 19, 2018
In 4Q17, Jazz Pharmaceuticals’ (JAZZ) Vyxeos (daunorubicin and cytarabine) generated revenues of $24 million compared to $10 million in 3Q17. In fiscal 2017, Vyxeos reported net revenues of $34 million.
Jazz Pharmaceuticals’ Xyrem, Erwinase, and Defitelio
Posted on Wednesday April 18, 2018
In 4Q17, Jazz Pharmaceuticals’ (JAZZ) Xyrem generated revenues of $312.5 million compared to $291 million in 4Q16. In fiscal 2017, Xyrem reported revenues of $1.2 billion compared to $1.1 billion in 2016, which reflected a 7% growth on a YoY basis. Xyrem is used for the treatment of cataplexy in narcolepsy and excessive daytime sleepiness in narcolepsy.